Abstract submission is closed!

All submitted abstracts have been reviewed by a Scientific Committee regarding scientific merit, relevance to the mission of the GEBIN and theoretical as well as methodological quality.

All accepted abstracts have been published in the journal Neuroimmunomodulation, at the 2023 GEBIN Conference website, as well as on the 2023 GEBIN Conftool website including title, name of authors, as well as authors’ affiliations. By submitting an abstract, all authors agreed with this policy.

We request to adhere to the following abstract guidelines:

• Please submit a structured abstract with a maximum length of 250 words.
• Abstracts should include the typical sections: background, methods, results, and conclusion.